USA - NASDAQ:GDRX - US38246G1085 - Common Stock
The current stock price of GDRX is 3.95 USD. In the past month the price decreased by -2.23%. In the past year, price decreased by -36.39%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.33 | 48.03B | ||
| DOCS | DOXIMITY INC-CLASS A | 44.86 | 12.52B | ||
| WAY | WAYSTAR HOLDING CORP | 35.11 | 7.44B | ||
| HTFL | HEARTFLOW INC | N/A | 3.16B | ||
| CERT | CERTARA INC | 25.84 | 2.03B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.67B | ||
| SDGR | SCHRODINGER INC | N/A | 1.66B | ||
| PHR | PHREESIA INC | N/A | 1.41B | ||
| CTEV | CLARITEV CORP | N/A | 1.15B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| EVH | EVOLENT HEALTH INC - A | N/A | 917.75M | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 909.88M |
GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The company is headquartered in Santa Monica, California and currently employs 738 full-time employees. The company went IPO on 2020-09-23. The firm connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The firm's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The firm partners with pharma manufacturers to advertise and integrate their affordability solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications.
GOODRX HOLDINGS INC-CLASS A
2701 Olympic Boulevard
Santa Monica CALIFORNIA 90404 US
CEO: Douglas Hirsch
Employees: 738
Phone: 18552682822
GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The company is headquartered in Santa Monica, California and currently employs 738 full-time employees. The company went IPO on 2020-09-23. The firm connects consumers, healthcare professionals, payers, pharmacy benefit managers (PBMs), pharma manufacturers, and retail pharmacies to make saving on medications easier. The firm's offerings include prescription marketplace and pharma manufacturer solutions. Its prescription marketplace consists of its prescription transactions offering and its supplemental subscription and telehealth offerings. Through its GoodRx Care platform, the Company offers consumers access to telehealth visits on a cash-pay basis outside of insurance. The firm partners with pharma manufacturers to advertise and integrate their affordability solutions into its platform. These solutions, provided by pharma manufacturers, include co-pay cards, patient assistance programs, care portals, and other savings options to ensure consumers can access their medications.
The current stock price of GDRX is 3.95 USD. The price increased by 2.33% in the last trading session.
GDRX does not pay a dividend.
GDRX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
21 analysts have analysed GDRX and the average price target is 5.43 USD. This implies a price increase of 37.36% is expected in the next year compared to the current price of 3.95.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on GDRX.
You can find the ownership structure of GOODRX HOLDINGS INC-CLASS A (GDRX) on the Ownership tab.
ChartMill assigns a technical rating of 1 / 10 to GDRX. When comparing the yearly performance of all stocks, GDRX is a bad performer in the overall market: 91.71% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to GDRX. GDRX has an average financial health and profitability rating.
Over the last trailing twelve months GDRX reported a non-GAAP Earnings per Share(EPS) of 0.35. The EPS increased by 16.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.33% | ||
| ROA | 2.62% | ||
| ROE | 5.38% | ||
| Debt/Equity | 0.75 |
21 analysts have analysed GDRX and the average price target is 5.43 USD. This implies a price increase of 37.36% is expected in the next year compared to the current price of 3.95.
For the next year, analysts expect an EPS growth of 15.26% and a revenue growth 0.55% for GDRX